These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22245379)

  • 1. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
    Kasina S; Macoska JA
    Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
    Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.
    Frigo DE; Sherk AB; Wittmann BM; Norris JD; Wang Q; Joseph JD; Toner AP; Brown M; McDonnell DP
    Mol Endocrinol; 2009 Sep; 23(9):1385-96. PubMed ID: 19460858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.
    Ueda T; Mawji NR; Bruchovsky N; Sadar MD
    J Biol Chem; 2002 Oct; 277(41):38087-94. PubMed ID: 12163482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
    Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
    Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.
    Bluemn EG; Spencer ES; Mecham B; Gordon RR; Coleman I; Lewinshtein D; Mostaghel E; Zhang X; Annis J; Grandori C; Porter C; Nelson PS
    Mol Cancer Res; 2013 Jun; 11(6):568-78. PubMed ID: 23493267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
    Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
    Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT; Wilson EM; Shapiro DJ
    J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X; Choi RY; Jawad SM; Arnold JT
    Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.
    Gioeli D; Black BE; Gordon V; Spencer A; Kesler CT; Eblen ST; Paschal BM; Weber MJ
    Mol Endocrinol; 2006 Mar; 20(3):503-15. PubMed ID: 16282370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.
    Conley-LaComb MK; Semaan L; Singareddy R; Li Y; Heath EI; Kim S; Cher ML; Chinni SR
    Mol Cancer; 2016 Nov; 15(1):68. PubMed ID: 27809841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
    Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW
    Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
    Lin DL; Whitney MC; Yao Z; Keller ET
    Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.